He who cures a disease may be the skill fullest, but he that prevents it is the safest physician. —Thomas Fuller 1608‐1661, English Clergyman and Historian.This comment, made by one of the most emblematic personalities of the 17th century, highlights the widely accepted opinion of preventing, rather than curing, a disease. Prevention of cardiovascular (CV) disease, the leading cause of death worldwide, remains a challenging aspect in clinical practice and requires the timely recognition of patients at risk for CV events. Arterial hypertension, diabetes mellitus, dyslipidemia, and obesity, along with other traditional risk factors, have been identified as strong and independent predictors of CV disease; however, even these established risk factors fail to fully predict CV events. Research efforts have been emphasizing in unveiling novel CV risk factors that alone, or in combination, could offer a better stratification of CV risk. For a marker to be established as a valid risk factor, strong data indicating an independent association between the marker and CV morbidity and mortality, along with evidence supporting the marker's ability to predict CV events beyond traditional risk factors, is needed. More importantly, the management of emerging risk factors should offer reduction in CV outcomes.Arterial stiffness is
Journal of Clinical Hypertension – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera